FallberichtOpen Access
Cisplatin’s Silent Toxicity: Hearing Loss, Ethics, and the Nursing Voice
Clinical Journal of Oncology Nursing · 01.08.2026
DOI: 10.1188/26.cjon.255-258 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical Journal of Oncology Nursing, online erschienen am 03.08.2026. Verfasst von Leslie Anne Worona. Beteiligte Einrichtung: Leslie Anne Worona. Hauptthemen laut MEDLINE: Antineoplastic Agents, Cisplatin, Hearing Loss, Neoplasms. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Ethik in der Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Antineoplastic AgentsCisplatinHearing LossNeoplasmsOtotoxicityHumansMaleOncology NursingAged
Stichwörter der Autor:innen
cisplatinethicsinformed consentototoxicityside effectssurvivorship
Substanzen
Antineoplastic AgentsCisplatin
Autor:innen und Institutionen
- Leslie Anne Worona.
Zitieren
APA
Worona, L. A. (2026). Cisplatin’s Silent Toxicity: Hearing Loss, Ethics, and the Nursing Voice. Clinical Journal of Oncology Nursing. https://doi.org/10.1188/26.cjon.255-258
Vancouver
Worona LA. Cisplatin’s Silent Toxicity: Hearing Loss, Ethics, and the Nursing Voice. Clinical Journal of Oncology Nursing. 2026. doi:10.1188/26.cjon.255-258
BibTeX
@article{Worona2026,
author = {Worona, Leslie Anne},
title = {Cisplatin’s Silent Toxicity: Hearing Loss, Ethics, and the Nursing Voice},
journal = {Clinical Journal of Oncology Nursing},
year = {2026},
doi = {10.1188/26.cjon.255-258}
}
EUVIMED